MediWound
MDWD
28 hedge funds and large institutions have $12.1M invested in MediWound in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 0 closing their positions.
115% more capital invested
Capital invested by funds: $5.63M → $12.1M (+$6.46M)
40% more funds holding
Funds holding: 20 → 28 (+8)
1.72% more ownership
Funds ownership: 1.34% → 3.07% (+1.7%)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $43K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3.45M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.57M |
| 3 |
ACM
Altium Capital Management
New York
|
+$2.3M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.24M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$525K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$87.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.3K |
| 3 |
Millennium Management
New York
|
-$22.9K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$14K |
| 5 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$9.52K |
MDWD Hedge Fund Activity: Q3 2022 in Review
28 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q3 2022, worth a combined $12.1M — up 115% from $5.63M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MDWD positions and 0 closed out — a net gain of 8 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $3.45M. The largest seller was Renaissance Technologies, cutting an estimated $87.1K.
- 28 institutional investors held MediWound (MDWD) as of Q3 2022, up from 20 in Q2 2022.
- Funds reported $12.1M of MediWound stock for Q3 2022, up 115% quarter-over-quarter.
- 8 funds opened new MediWound positions in Q3 2022 and 0 closed out, a net change of +8 holders.
- The largest MediWound buyer in Q3 2022 was Armistice Capital, an estimated $3.45M added.
- The largest MediWound seller in Q3 2022 was Renaissance Technologies, an estimated $87.1K sold.
Based on aggregated 13F filings for Q3 2022.